These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 16243890)

  • 61. [Pseudomonas aeruginosa--a bacteriological ghost].
    Midtvedt T
    Tidsskr Nor Laegeforen; 1969 Feb; 89(3):190. PubMed ID: 4307572
    [No Abstract]   [Full Text] [Related]  

  • 62. Clinical response to azithromycin in cystic fibrosis correlates with in vitro effects on Pseudomonas aeruginosa phenotypes.
    Nguyen D; Emond MJ; Mayer-Hamblett N; Saiman L; Marshall BC; Burns JL
    Pediatr Pulmonol; 2007 Jun; 42(6):533-41. PubMed ID: 17469154
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pulmonary infection in mild variant cystic fibrosis: implications for care.
    Lording A; McGaw J; Dalton A; Beal G; Everard M; Taylor CJ
    J Cyst Fibros; 2006 May; 5(2):101-4. PubMed ID: 16426904
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis.
    Ferroni A; Guillemot D; Moumile K; Bernede C; Le Bourgeois M; Waernessyckle S; Descamps P; Sermet-Gaudelus I; Lenoir G; Berche P; Taddei F
    Pediatr Pulmonol; 2009 Aug; 44(8):820-5. PubMed ID: 19598278
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Once-weekly azithromycin in cystic fibrosis with chronic Pseudomonas aeruginosa infection.
    Steinkamp G; Schmitt-Grohe S; Döring G; Staab D; Pfründer D; Beck G; Schubert R; Zielen S
    Respir Med; 2008 Nov; 102(11):1643-53. PubMed ID: 18701270
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Pseudomonas aeruginosa as a pathogen in opportunistic infections].
    Dalhoff A
    Infection; 1987; 15 Suppl 2():S60-3. PubMed ID: 3112022
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Implementation of European standards of care for cystic fibrosis--control and treatment of infection.
    Elborn JS; Hodson M; Bertram C
    J Cyst Fibros; 2009 May; 8(3):211-7. PubMed ID: 19372063
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Aerosol antibiotics: considerations in pharmacological and clinical evaluation.
    Dudley MN; Loutit J; Griffith DC
    Curr Opin Biotechnol; 2008 Dec; 19(6):637-43. PubMed ID: 19036576
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A phase 2 study of aztreonam lysine for inhalation to treat patients with cystic fibrosis and Pseudomonas aeruginosa infection.
    Retsch-Bogart GZ; Burns JL; Otto KL; Liou TG; McCoy K; Oermann C; Gibson RL;
    Pediatr Pulmonol; 2008 Jan; 43(1):47-58. PubMed ID: 18041081
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antibiotic treatment for patients with acute exacerbations of chronic bronchitis.
    Pacios E; Gestoso I; Villarroel P
    Clin Microbiol Infect; 2007 Jul; 13(7):747-8. PubMed ID: 17441978
    [No Abstract]   [Full Text] [Related]  

  • 71. Antibiotic-resistant Pseudomonas aeruginosa in cystic fibrosis.
    Van Devanter DR
    Respiration; 2007; 74(3):356; author reply 357. PubMed ID: 17204830
    [No Abstract]   [Full Text] [Related]  

  • 72. [Colistin as last resort in 2 patients with pulmonary infection with multiresistant nosocomial bacteria].
    Ekkelenkamp MB; Bonten MJ
    Ned Tijdschr Geneeskd; 2006 May; 150(18):1022-6. PubMed ID: 16715867
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Transfusion medicine illustrated. Profound piperacillin-mediated drug-induced immune hemolysis in a patient with cystic fibrosis.
    Gehrie E; Neff AT; Ciombor KK; Harris N; Seegmiller AC; Young PP
    Transfusion; 2012 Jan; 52(1):4-5. PubMed ID: 22032241
    [No Abstract]   [Full Text] [Related]  

  • 74. Fosfomycin--investigation of a possible new route of administration of an old drug. A case study.
    Cree M; Stacey S; Graham N; Wainwright C
    J Cyst Fibros; 2007 May; 6(3):244-6. PubMed ID: 17055346
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Successful treatment with doripenem and tobramycin of ventriculitis due to imipenem- and meropenem-resistant Pseudomonas aeruginosa.
    Gelfand MS; Cleveland KO; Mazumder SA
    J Antimicrob Chemother; 2009 Jun; 63(6):1297-9. PubMed ID: 19369268
    [No Abstract]   [Full Text] [Related]  

  • 76. [Bacterial infections in cancer patients].
    Krankenpfl J; 2005; 43(1-3):42-3. PubMed ID: 15912833
    [No Abstract]   [Full Text] [Related]  

  • 77. [Cystic fibrosis and pseudomonas aeruginosa current and future strategies].
    Leonard A; Leal T; Lebecque P
    J Pharm Belg; 2007; 62(1):25-8. PubMed ID: 17508664
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Successful treatment of multidrug-resistant Pseudomonas aeruginosa meningitis with intravenous and intrathecal colistin.
    Schina M; Spyridi E; Daoudakis M; Mertzanos E; Korfias S
    Int J Infect Dis; 2006 Mar; 10(2):178-9. PubMed ID: 16263315
    [No Abstract]   [Full Text] [Related]  

  • 79. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment.
    Marcus N; Ashkenazi S; Samra Z; Cohen A; Livni G
    Infection; 2008 Oct; 36(5):421-6. PubMed ID: 18795227
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Pseudomonas aeruginosa infections in turkey poults and treatment trials with apramycin].
    Hafez HM; Woernle H; Heil G
    Berl Munch Tierarztl Wochenschr; 1987 Feb; 100(2):48-51. PubMed ID: 3105524
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.